These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9809500)

  • 1. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
    Stern MA; Wade AG; Ridout SM; Cambell LM
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis.
    Day J; Carrillo T
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):902-8. PubMed ID: 9847429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.
    Fokkens WJ; Cserháti E; dos Santos JM; Praca F; van Zanten M; Schade A; Simon G
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):279-84. PubMed ID: 12269648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
    Meltzer EO
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ; Lund VJ; Harten-Ash VJ
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
    Herman D; Garay R; Le Gal M
    Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
    Golden SJ; Craig TJ
    J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S7-12. PubMed ID: 10478514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome.
    Rinne J; Simola M; Malmberg H; Haahtela T
    J Allergy Clin Immunol; 2002 Mar; 109(3):426-32. PubMed ID: 11897986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of azelastine nasal spray and cetirizine tablets in the treatment of allergic rhinitis.
    Passali D; Piragine F
    J Int Med Res; 1994; 22(1):17-23. PubMed ID: 8187941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis.
    Ratner PH; Findlay SR; Hampel F; van Bavel J; Widlitz MD; Freitag JJ
    J Allergy Clin Immunol; 1994 Nov; 94(5):818-25. PubMed ID: 7963150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis.
    Kivisaari E; Baker RC; Price MJ
    Clin Exp Allergy; 2001 Jun; 31(6):855-63. PubMed ID: 11422149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.